Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SCIENTURE HOLDINGS announced the initiation of supply chain activities by its wholly owned subsidiary Scienture, LLC to manufacture launch quantities of Arbli™ (losartan potassium) Oral Suspension, 10 mg/mL for the intended commercial launch of the ...
read more
CARBOGEN AMCIS announced that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).
The NMPA approval followed a rigorous review focused on GMP ...
read more
1ST Biotherapeutics, Inc. and LigaChem Biosciences have entered into a strategic partnership and licensing option agreement to co-develop novel payloads for antibody-drug conjugates (ADCs) as well as small molecule immuno-oncology therapies.
read more
Phlow Corp. announced a significant expansion in its analytical capabilities, use of artificial intelligence (AI), workforce, and domestic infrastructure.
read more
Thermo Fisher Scientific announced the opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, Calif. This advanced facility is designed to accelerate the development and commercialization of cell therapies, specifically by ...
read more
ViroCell Biologics announced the opening of a University College London clinical trial to advance Professor Persis Amrolia’s innovative chimeric antigen receptor (CAR) T-cell therapy for relapsed pediatric acute lymphoblastic leukemia (ALL). Dr. ...
read more
CluePoints has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.
read more
Sirio Pharma announced the appointment of Mark Dewis as General Manager of the Sirio Americas Business Unit. Dr. Dewis brings more than 30 years of experience in the food, beverage, and nutritional supplement industries.
read more
Concept Life Sciences announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors.
read more
Meribel Pharma Solutions has launched with ten manufacturing sites and three drug development services sites, situated across France, Spain and Sweden, following the acquisition of CDMO, Synerlab Group and seven European manufacturing facilities from...
read more
PRISM BioLab, Co. has entered into a drug discovery collaboration with Elix, Inc. The partnership will accelerate research on small molecule inhibitors of protein-protein interaction (PPI) targets by combining PRISM BioLab's proprietary peptide ...
read more
Wednesday, April 09, 2025
Worldwide Clinical Trials has added a cutting-edge artificial intelligence (AI) tool to enhance clinical trial optimization. This new service segments patient populations to identify those most likely to drive a positive trial outcome, leading to ...
read more
Wednesday, April 09, 2025
PharmaLogic Holdings Corp. will acquire a majority stake in Agilera Pharma AS from the Institute for Energy Technology (IFE) in Norway, marking a significant step forward in the company's strategy to create the first fully-integrated, global CDMO ...
read more
Asahi Kasei has established Asahi Kasei Life Science, a new organizational structure dedicated to its bioprocess businesses. This move reflects the company’s commitment to addressing the evolving needs of the pharmaceutical industry by enhancing ...
read more
Clean Cells, part of the Clean Biologics group, announced the strategic acquisition of Karyologic Inc., a specialized karyotyping services company based in Durham, North Carolina, USA. This strategic acquisition marks a key milestone in Clean Cells’ ...
read more